Atlassian (TEAM) stock is down 25% on AI fears—see why its moat, switching costs, and 30% growth outlook may signal upside.

DENVER, CO / ACCESS Newswire / January 20, 2026 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (Nasdaq:AYTU), a pharmaceutical company focused on advancing innovative medicines for complex central ...

The moment he’d been dreaming of for the past 150 days, an eternity for a six-year-old kid, was finally here. The first ...

As Dr. Christopher Bellavita observed in his 2008 article "Changing Homeland Security: What is Homeland Security?", "The ...

New data show cancer survival has reached a record high — nearly 70% of patients now live at least five years after diagnosis ...

The reaction relies on an organoboron reagent to prime the epoxide for skeletal remodeling and a zinc salt to initiate the ...

During chemical reactions, atoms in the reacting substances break their bonds and re-arrange, forming different chemical ...

Sarepta Therapeutics, Inc. reported FY25 revenue of $1.86B, maintains a robust cash position of $953.8M. Click here to read ...

Sum-frequency generation (SFG) is a powerful vibrational spectroscopy that can selectively probe molecular structures at ...

Antidepressants increase the risk of suicidal thoughts and behaviors in pediatric and young adult patients in short-term studies. Closely monitor all antidepressant-treated patients for clinical ...

Explainer - The agreement eliminates duty on 100 percent of Indian imports, while 95 percent of New Zealand's current exports ...

A new scientific review outlines how a little understood class of battery materials could help deliver safer, higher energy lithium ion batteries ...